IQVIA™ Real-World Insights Bibliography

Effectiveness and safety of empagliflozin in routine care in Europe and East Asia: results from the empagliflozin comparative effectiveness and safety (EMPRISE) study
Author(s): A. Karasik1 , S. Lanzinger2 , E. Chia-Hui Tan3 , D. Yabe4 , D. Jung Kim5 , W. H-H Sheu6 , C. MelzerCohen1 , R.W. Holl2 , K. Ha5 , T. Nyström7 , L. Niskanen8 , M. Linnemann Jensen9 , M.H. Kyaw10, J. Núñez11, EMPRISE EU and East Asia Study Group;
Affiliations(s): Maccabi Research & Innovation Center, Tel Aviv University, Tel Aviv, Israel, 2 Inst. for Epidemiology & Medical Biometry, Uni. of Ulm, Ulm, Germany, 3National Research Inst. of Chinese Medicine, Taipei, Taiwan, 4Dept. of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, Gifu, Japan, 5Dept. of Endocrinology & Metabolism, Ajou Uni. School of Medicine, Suwon, Republic of Korea, 6Taipei Veterans General Hospital, Taipei, Taiwan, 7Dept. of Clinical Science & Education, Södersjukhuset, Karolinska Institutet, Solna, Sweden, 8Department of Medicine, Päijät-Häme Central Hospital, Lahti, Finland, 9 IQVIA, Copenhagen, Denmark, 10Boehringer Ingelheim Pharmaceutical Inc., Ridgefield, USA, 11Dept. of Cardiology, Hospital Clínico Universitario de Valencia, Valencia, Spain
Publication(s):  https://doi.org/10.2337/DB21-127-LB
Virtual EASD 2021, 57 Annual Meeting, 27 September - 10 October 2021
Document Type(s): Abstract,
Countries: Finland, Germany, Israel, Japan, South Korea, Spain, Sweden, Taiwan,
Click here for the abstract
C:
Y:
Cardiovascular disease, Diabetes,
2021
  L:
A:
English
Database Study, Methodology, Population Based Study,
  Add to report
 
 
Cardiovascular Effectiveness of Empagliflozin Compared to DPP-4i in Routine Care in East Asia: Results from the EMPRISE study
Author(s): Dae Jung Kim, Wayne H.-H. Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Elise Chia-Hui Tan, Yusuke Taneda, Vanessa Lei, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H. Kyaw, Yutaka Seino, EMPRISE East Asia Study Group, Boehringer Ingelheim International GmbH, Ingelheim, Germany, StatFinn - EPID Research an IQVIA Company, Espoo, Finland
Affiliations(s): 1 Ajou University, Suwon, South Korea; 2 Taichung Veterans General Hospital, Taichung, Taiwan; 3 Gachon University Gil Medical Center, Incheon, South Korea; 4 Kansai Electric Power Medical Research Institute, Kobe, Japan; 5 Gifu University Graduate School of Medicine, Gifu, Japan; 6 National Research Institute of Chinese Medicine, Taipei, Taiwan; 7 Nippon Boehringer Ingelheim Co. Ltd., Tokyo, Japan; 8 Boehringer Ingelheim Taiwan Ltd., Taipei, Taiwan; 9 IQVIA, Espoo, Finland; 10 Boehringer Ingelheim International GmbH, Ingelheim, Germany; 11 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 12 Kansai Electric Power Hospital, Osaka, Japan
Publication(s):  J Am Coll Cardiol. 2021 May, 77 (18_Supplement_1) 542. https://doi.org/10.1016/S0735-1097(21)01901-X
Document Type(s): Abstract, Presentation,
Countries: Japan, South Korea, Taiwan,
Click here for the abstract
C:
Y:
Cardiovascular disease, Diabetes,
2021
  L:
A:
English
Database Study, Methodology, Observational study,
  Add to report
 
 
Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study
Author(s): Yutaka Seino*, Dae Jung Kim, Daisuke Yabe, Elise Chia-Hui Tan, Wook-Jin Chung, Kyoung Hwa Ha, Masaomi Nangaku, Koichi Node, Riho Klement**, Atsutaka Yasui, Wei-Yu, Sunwoo Lee, Moe H Kyaw, Anouk Deruaz-Luyet, Kimberly G Brodovicz,Wayne H-H Sheu, on behalf of the EMPRISE East Asia study group
Affiliations(s): * Kansai Electric Power Medical Research Institute, Kobe, Japan and Kansai Electric Power Hospital, Osaka, Japan **EPID Research an IQVIA company, Tartu, Estonia
Publication(s):  Endocrinology, Diabetes and Metabolism 2020;00:e00183
Document Type(s): Article,
Countries: Japan, South Korea, Taiwan,
Click here for the abstract
C:
Y:
Cardiovascular disease, Diabetes,
2020
  L:
A:
English
Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Cross-sectional study estimating the psychosocial impact of genital warts and other anogenital diseases in South Korea
Author(s): Lee TS1, Kothari-Talwar S2, Singhal PK2, Yee K3, Kulkarni A2, Lara N4, Roset M4, Giuliano AR5, Garland SM6, Ju W7
Affiliations(s): 1 Department of Obstetrics and Gynecology, SMG-SNU Boramae Medical Center, Seoul, South Korea 2 Merck and Co Inc, Kenilworth, NJ, US 3 Cubist Pharmaceuticals Inc, Lexington, MA, US 4 IQVIA, Barcelona, Spain 5 Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, US 6 Microbiology and Infectious Diseases Department, The Royal Women's Hospital, Parkville, Victoria, Australia 7 School of Medicine, Ewha Womans University, Seoul, South Korea
Publication(s):  BMJ Open. 2019 Mar 20;9(3):e025035
Document Type(s): Article,
Countries: South Korea,
Click here for the abstract
C:
Y:
Infectious disease,
2019
  L:
A:
English
Burden of illness, Clinical setting: Primary care, clinical setting: Secondary care,
  Add to report
 
 
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Author(s): Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations(s): 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publication(s): 
Document Type(s): 
Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK,
Click here for the abstract
C:
Y:

2018
  L:
A:
English
  Add to report
 
 
Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries
Author(s): Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2
Affiliations(s): 1IQVIA , Milan, Italy 2IQVIA , London, UK
Publication(s):  ESMO 2018
Document Type(s): Poster,
Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK,
Click here for the abstract
C:
Y:
Oncology,
2018
  L:
A:
English
  Add to report
 
 
Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis
Author(s):  Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R, Payne H 1
Affiliations(s): 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publication(s):  ESMO 2018
Document Type(s): Poster,
Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK,
Click here for the abstract
C:
Y:
Oncology,
2018
  L:
A:
English
  Add to report
 
 
Initial Management of localised prostate cancer in the Elderly: An International Data Review
Author(s): Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1
Affiliations(s): 1 University College Hospital, London, UK 2 IQVIA , London, UK
Publication(s):  SIOG 2018
Document Type(s): Poster,
Countries: China, France, Germany, Italy, Japan, South Korea, Spain, UK,
C:
Y:
Oncology,
2018
  L:
A:
English
  Add to report
 
 
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia
Author(s): Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3
Affiliations(s): 1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA
Publication(s):  JCO ( ASCO 2018)
Document Type(s): Abstract,
Countries: Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK,
Click here for the abstract
C:
Y:
Oncology,
2018
  L:
A:
English
  Add to report
 
 
The cost-effectiveness of travoprost preserved with polyquad® in newly treated open-angle glaucoma patients in 7 Asian countries.
Author(s): Gerlier L1, Lamotte M1, Caputo J2, Tan R3
Affiliations(s): 1 IMS Health Consulting EMEA, Vilvoorde, Belgium 2 IMS Health Consulting Asia-Pacific, Singapore 3 ALCON, Asia-Pacific, Singapore
Publication(s):  5th ISPOR Asia-Pacific Conference, 2012, September 2-4, Taipei, Taiwan
Document Type(s): Abstract, Poster,
Countries: India, Malaysia, Singapore, South Korea, Thailand,
C:
Y:
Ophthalmology,
2012
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
 1 of 2 Next Page Last Page